Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Pulmonx (LUNG) Shares Outstanding (Weighted Average) (2019 - 2025)

Pulmonx has reported Shares Outstanding (Weighted Average) over the past 7 years, most recently at $41.7 million for Q4 2025.

  • Quarterly Shares Outstanding (Weighted Average) rose 6.55% to $41.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $41.7 million through Dec 2025, up 6.55% year-over-year, with the annual reading at $41.7 million for FY2025, 6.55% up from the prior year.
  • Shares Outstanding (Weighted Average) was $41.7 million for Q4 2025 at Pulmonx, up from $40.9 million in the prior quarter.
  • Over five years, Shares Outstanding (Weighted Average) peaked at $41.7 million in Q4 2025 and troughed at $35.4 million in Q1 2021.
  • The 5-year median for Shares Outstanding (Weighted Average) is $37.8 million (2023), against an average of $38.1 million.
  • Year-over-year, Shares Outstanding (Weighted Average) soared 1758.78% in 2021 and then rose 1.87% in 2023.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $36.1 million in 2021, then grew by 2.68% to $37.1 million in 2022, then rose by 2.37% to $38.0 million in 2023, then rose by 2.99% to $39.1 million in 2024, then rose by 6.55% to $41.7 million in 2025.
  • Per Business Quant, the three most recent readings for LUNG's Shares Outstanding (Weighted Average) are $41.7 million (Q4 2025), $40.9 million (Q3 2025), and $40.4 million (Q2 2025).